Richards, R., Burls, A., & Payne, N. (2000). Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
Cita Chicago (17th ed.)Richards, R., A. Burls, i N. Payne. Cost Utility of Drugs for Multiple Sclerosis. Methods Used Don't Calculate True Benefit. 2000.
Cita MLA (9th ed.)Richards, R., et al. Cost Utility of Drugs for Multiple Sclerosis. Methods Used Don't Calculate True Benefit. 2000.
Atenció: Aquestes cites poden no estar 100% correctes.